Myriam Mendila
Corporate Officer/Principal chez CUREVAC N.V.
Profil
Myriam Mendila is currently working as the Co-Managing Director at CureVac NV.
Previously, she worked as the Chief Medical Officer-Oncology at Novartis Pharma AG.
She holds a doctorate degree from Hannover Medical School.
Postes actifs de Myriam Mendila
| Sociétés | Poste | Début |
|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 01/02/2023 |
Anciens postes connus de Myriam Mendila
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formation de Myriam Mendila
| Hannover Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
